(Date:11/24/2009)...wire-FirstCall/ -- IES (Nasdaq: IESC ), a leading...s systems and services for the commercial, industr...its commercial business group has been awarded a c...ectrical systems for the Level 4 bio-safety lab (B...l Research Institute of Infectious Diseases (USAMR...
(Date:11/24/2009)...Iceland, November 24 deC... that it has received notice from,the Nasdaq Stock... will be,suspended as of November 30, 2009 and a F...xchange Commission, which will remove deCODE,s com...ny files an appeal to the Nasdaq,Listing Qualifica...
(Date:11/24/2009)...24 NeurogesX, Inc. (Nasd...n developing and commercializing novel pain manage...no, President and Chief Executive Officer, is sche...Health Care Conference, to be held December 1-2, 2...York. ,, Mr. DiTonno and Stephen Ghiglieri, Ch...
(Date:11/24/2009)...ONTO, Nov. 24 /PRNewswire-FirstCall/ - Hamilton Th...nc., a leading provider of advanced laser systems ...tility clinic markets, today reported operational ...September 30, 2009. , , Q3 2009 Highlights, ...3 million in Q3 2008, - Gross profit margin w...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10... 11 Nektar Therapeutics,(Nasdaq: NKTR ) will an...r and,year ended December 31, 2008 on Wednesday, F...nancial markets. Howard Robin, president and chie...o review the results beginning at,5:00 p.m. Easter... press release and a live audio-only Webcast of th...
...b. 11 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB...man and Mr. Boaz Shweiger have been appointed to X...tion, Mr. Grossman will also be assuming,the role ...n, to assist in,XTL,s analysis of its strategic al...Officer of XTL, commented, "We decided to,make the...
...entists engaged in biological research and drug di...9 lab budgets. BioInformatics, LLC ( www.gene2dru...rving the life science market, has released prelim...pering in a Down Market: Strategies for Life Scien... understand current sources of funding for researc...
Other Biology Technology:Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets 2XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 2XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors 3Life Science Labs Reacting to the Economic Crisis 2Mouse GM-CSF ELISpot Development Kit from R&D Systems
...t contains the basic components required for the d...nd recombinant rat Thymus Chemokine-1 in cell cult...ient materials to run ELISAs on approximately fift...nditions are met: The assay is run as summarized...
Custom Conjugation Services from SoluLink
Rabbit Anti-Blimp-1 (H-150) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: